CRH PLC
CRH
81.46
-2.14
-2.56%
CRH PLC
US · CRH
#393 by market cap
Listed 1970
81.46
-2.14
-2.56%
Live - 5344 symbols - heartbeat 198s ago
· 2026-10-08 08:07
Pre-market
81.00
-0.56%
After-hours
82.01
+0.68%
Overnight
81.46
0.00%
- Market cap
- 54.19B
- P/E (TTM)i
- 14.39
- P/Bi
- 2.25
- EPSi
- 5.51
- Div yieldi
- 1.87%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on CRH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.68, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.27% YoY
Margins
- Gross margin
- 36.13%
- Operating margin
- 14.21%
- Net margin
- 9.96%
Key ratios & quality
- Enterprise valuei
- 68.15B
- Altman Z-Scorei
- 2.68
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 27.45B | 28.13B | 25.89B | 29.21B | 32.72B | 34.95B | 35.57B | 37.45B |
| Gross profit | 9.06B | 9.27B | 8.57B | 9.83B | 10.82B | 11.96B | 12.70B | 13.53B |
| Selling & admin expenses | 6.61B | 6.48B | 6.54B | 6.54B | 7.06B | 7.34B | 7.63B | 8.01B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.45B | 2.79B | 2.03B | 3.29B | 3.76B | 4.49B | 4.92B | 5.32B |
| Pretax profit | 1.97B | 2.18B | 1.45B | 3.10B | 3.46B | 4.01B | 4.71B | 4.81B |
| Tax | 467.00M | 534.00M | 445.00M | 650.00M | 762.00M | 925.00M | 1.09B | 1.04B |
| Net profit | 2.89B | 1.74B | 1.17B | 2.69B | 3.89B | 3.07B | 3.52B | 3.79B |
| Basic EPS | 3 | 2 | 1 | 3 | 5 | 4 | 5 | 6 |
| Diluted EPS | 3.45 | 2.13 | 1.42 | 3.32 | 5.11 | 4.33 | 5.02 | 5.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 6.76B | 10.21B | 11.07B | 9.42B | 7.37B | 10.78B |
| Gross profit | 1.84B | 4.03B | 4.31B | 3.36B | 2.05B | 4.29B |
| Selling & admin expenses | 1.83B | 2.12B | 2.34B | 1.72B | 2.06B | 2.27B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.00M | 1.91B | 1.97B | 1.44B | -12.00M | 2.03B |
| Pretax profit | -146.00M | 1.76B | 1.92B | 1.27B | -224.00M | 2.16B |
| Tax | -58.00M | 425.00M | 428.00M | 246.00M | -55.00M | 661.00M |
| Net profit | -98.00M | 1.33B | 1.52B | 1.04B | -180.00M | 1.51B |
| Basic EPS | 0 | 2 | 2 | 2 | 0 | 2 |
| Diluted EPS | -0.15 | 1.94 | 2.21 | 1.52 | -0.27 | 2.21 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 17.40B | 17.26B | 14.98B | 14.04B | 14.83B | 16.89B | 14.08B | 15.25B |
| Cash & ST investments | 9.19B | 9.92B | 7.72B | 5.78B | 5.93B | 6.34B | 3.72B | 4.10B |
| Inventory | 3.51B | 3.08B | 3.12B | 3.61B | 4.19B | 4.29B | 4.76B | 5.25B |
| Total assets | 46.78B | 47.61B | 44.94B | 44.67B | 45.32B | 47.47B | 50.61B | 58.33B |
| Total current liabilities | 13.47B | 12.87B | 7.47B | 7.58B | 8.04B | 10.01B | 10.30B | 8.75B |
| Short-term debt | 7.21B | 6.92B | 1.55B | 846.00M | 1.73B | 2.12B | 3.33B | 1.58B |
| Long-term debt | 9.96B | 9.21B | 10.96B | 9.94B | 8.15B | 9.78B | 10.97B | 16.48B |
| Total liabilities | 27,825,000,000.00 | 27,977,000,000.00 | 24,596,000,000.00 | 23,756,000,000.00 | 22,279,000,000.00 | 25,848,000,000.00 | 27,763,000,000.00 | 32,851,000,000.00 |
| Total equity | 18.95B | 19.64B | 20.35B | 20.91B | 23.04B | 21.62B | 22.85B | 25.48B |
| Retained earnings | 11.71B | 11.35B | 11.57B | 19.77B | 22.50B | 22.92B | 24.04B | 25.59B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 14.24B | 15.15B | 16.85B | 15.25B | 16.24B | 15.75B |
| Cash & ST investments | 3.70B | 2.88B | 4.20B | 4.10B | 3.24B | 3.03B |
| Inventory | 4.96B | 5.05B | 5.02B | 5.25B | 5.06B | 5.10B |
| Total assets | 51.92B | 53.98B | 58.53B | 58.33B | 58.17B | 58.55B |
| Total current liabilities | 8.71B | 8.68B | 11.60B | 8.75B | 10.21B | 9.98B |
| Short-term debt | 1.71B | 1.42B | 4.32B | 1.58B | 2.84B | 2.89B |
| Long-term debt | 14.21B | 14.64B | 14.73B | 16.48B | 16.07B | 15.41B |
| Total liabilities | 29,564,000,000.00 | 30,354,000,000.00 | 33,898,000,000.00 | 32,851,000,000.00 | 33,622,000,000.00 | 33,017,000,000.00 |
| Total equity | 22.36B | 23.63B | 24.63B | 25.48B | 24.55B | 25.54B |
| Retained earnings | 23.38B | 24.11B | 25.07B | 25.59B | 24.79B | 25.74B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.25B | 3.88B | 3.94B | 3.98B | 3.80B | 5.02B | 4.99B | 5.63B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 922.00M | 2.51B | 2.94B | 2.43B | 2.28B | 3.20B | 2.41B | 2.91B |
| Dividends paid | -619.00M | -652.00M | -707.00M | -906.00M | -917.00M | -940.00M | -1.71B | -996.00M |
| Stock buybacks / issuance | -897.00M | -932.00M | -243.00M | -883.00M | -1.17B | -3.06B | -1.47B | -1.23B |
| Ending cash balance | 2.69B | 4.22B | 7.72B | 5.78B | 5.94B | 6.39B | 3.76B | 4.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -659.00M | 1.38B | 1.99B | 2.92B | -616.00M | 1.13B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -1.30B | 723.00M | 1.40B | 2.09B | -1.22B | 490.00M |
| Dividends paid | -- | -- | -249.00M | -247.00M | -- | -- |
| Stock buybacks / issuance | -309.00M | -391.00M | -285.00M | -243.00M | -330.00M | -343.00M |
| Ending cash balance | 3.35B | 2.88B | 4.29B | 4.15B | 3.33B | 3.08B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.12 | 11.58 | 5.81 | 12.86 | 18.35 | 14.94 | 16.45 | 16.36 |
| ROA %i | 7.37 | 5.27 | 2.59 | 5.72 | 8.56 | 6.86 | 7.12 | 6.85 |
| ROIC %i | 11.31 | 8.39 | 4.52 | 8.85 | 12.64 | 9.95 | 10.89 | 10.54 |
| 5-year avg ROE %i | 10.17 | 10.91 | 10.88 | 11.71 | 12.51 | 12.21 | 13.63 | 15.74 |
| EBIT margin %i | 8.34 | 10.14 | 7.74 | 12.27 | 11.86 | 12.56 | 14.97 | 14.99 |
| FCF / sales %i | 2.90 | 8.90 | 10.66 | 8.57 | 7.43 | 9.16 | 6.78 | 7.78 |
| Current ratioi | 1.29 | 1.34 | 2.01 | 1.85 | 1.84 | 1.69 | 1.37 | 1.74 |
| Quick ratioi | 1.03 | 1.10 | 1.55 | 1.33 | 1.27 | 1.08 | 0.83 | 1.06 |
| Debt / assetsi | 36.71 | 36.81 | 30.82 | 27.22 | 23.99 | 27.43 | 30.75 | 33.78 |
| LT debt / equityi | 54.28 | 55.73 | 62.56 | 55.91 | 41.28 | 52.28 | 56.62 | 75.52 |
| Interest coveragei | 6.02 | 5.90 | 4.53 | 8.30 | 9.42 | 11.68 | 8.70 | 6.93 |
| Revenue CAGR (3Y) %i | 2.03 | 2.57 | -0.11 | 2.09 | 5.17 | 10.52 | 6.79 | 4.60 |
| Net income CAGR (3Y) %i | 53.88 | 9.51 | -20.97 | -3.03 | 31.02 | 41.13 | 9.55 | -1.15 |
| FCF CAGR (3Y) %i | -14.83 | 17.04 | 28.90 | 38.04 | -3.16 | 2.84 | -0.19 | 8.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.96 | 15.34 | 15.23 | 16.36 | 16.51 | 16.45 |
| ROA %i | 6.68 | 6.47 | 6.27 | 6.85 | 6.63 | 6.78 |
| ROIC %i | 10.21 | 10.02 | 9.66 | 10.54 | 10.28 | 10.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.33 | 14.30 | 14.28 | 14.99 | 14.61 | 15.49 |
| FCF / sales %i | 6.50 | 6.02 | 7.06 | 7.78 | 7.88 | 7.16 |
| Current ratioi | 1.63 | 1.74 | 1.45 | 1.74 | 1.59 | 1.58 |
| Quick ratioi | 1.02 | 1.08 | 0.96 | 1.06 | 0.83 | 0.98 |
| Debt / assetsi | 32.73 | 31.78 | 35.29 | 33.78 | 35.12 | 33.84 |
| LT debt / equityi | 72.39 | 70.44 | 70.07 | 75.52 | 76.22 | 70.41 |
| Interest coveragei | 7.77 | 7.37 | 7.02 | 6.93 | 6.68 | 7.03 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Road Solutions is the largest reported line at 43.32% of revenue, across 4 reported segments.
- No single line clears half of revenue; Essential Materials is next at 29.94%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Road Solutions43.32%
Essential Materials29.94%
Outdoor Living Solutions14.39%
Building & Infrastructure Solutions12.34%
Quote time 2026-10-08 08:07:18 · For reference only, not investment advice and not tailored to your situation.